These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29916217)

  • 1. Role of erythropoietin and its receptor in the development of endometriosis in rats.
    Günal MY; Ozansoy M; Kılıç Ü; Keskin İ; Özdemir EM; Aslan İ; Eren Z; Ersavaş C; Kılıç E
    J Turk Ger Gynecol Assoc; 2019 Feb; 20(1):41-46. PubMed ID: 29916217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin (EPO) ameliorates obesity and glucose homeostasis by promoting thermogenesis and endocrine function of classical brown adipose tissue (BAT) in diet-induced obese mice.
    Kodo K; Sugimoto S; Nakajima H; Mori J; Itoh I; Fukuhara S; Shigehara K; Nishikawa T; Kosaka K; Hosoi H
    PLoS One; 2017; 12(3):e0173661. PubMed ID: 28288167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different effects of erythropoietin in cisplatin- and docetaxel-induced neurotoxicity: an in vitro study.
    Maggioni D; Nicolini G; Chiorazzi A; Meregalli C; Cavaletti G; Tredici G
    J Neurosci Res; 2010 Nov; 88(14):3171-9. PubMed ID: 20722073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of erythropoietin and erythropoietin receptor in peritoneal endometriosis.
    Matsuzaki S; Canis M; Yokomizo R; Yaegashi N; Bruhat MA; Okamura K
    Hum Reprod; 2003 Jan; 18(1):152-6. PubMed ID: 12525458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methoxy polyethylene glycol-epoetin beta for the treatment of anemia associated with chronic renal failure.
    Schmid H
    Expert Rev Hematol; 2016 Jan; 9(1):5-20. PubMed ID: 26573694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rise in RBC aggregability and concomitant decrease in blood pressure 10 days after injection of the long acting erythropoietin analogue methoxy polyethylene glycol-epoetin-β (MIRCERA®).
    Joré C; Brun JF; Varlet-Marie E
    Clin Hemorheol Microcirc; 2016; 64(4):809-816. PubMed ID: 27767968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methoxy Polyethylene Glycol-Epoetin Beta as a Novel Erythropoiesis Stimulating Agent with Possible Nephroprotective and Cardiovascular Protective Effects in Non-Dialysis Chronic Kidney Disease Patients.
    Piotr B; Mariusz S; Jacek R
    Curr Pharm Biotechnol; 2017; 18(4):303-308. PubMed ID: 28137221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1/-2.
    Kilic U; Kilic E; Soliz J; Bassetti CI; Gassmann M; Hermann DM
    FASEB J; 2005 Feb; 19(2):249-51. PubMed ID: 15556972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epoetin beta pegol, but not recombinant erythropoietin, retains its hematopoietic effect in vivo in the presence of the sialic acid-metabolizing enzyme sialidase.
    Aizawa K; Kawasaki R; Tashiro Y; Hirata M; Endo K; Shimonaka Y
    Int J Hematol; 2016 Aug; 104(2):182-9. PubMed ID: 27084258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARCOSYL-PAGE: a new method for the detection of MIRCERA- and EPO-doping in blood.
    Reichel C; Abzieher F; Geisendorfer T
    Drug Test Anal; 2009 Nov; 1(11-12):494-504. PubMed ID: 20355164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of erythropoietin axotomy-induced apoptosis in rat retinal ganglion cells.
    Weishaupt JH; Rohde G; Pölking E; Siren AL; Ehrenreich H; Bähr M
    Invest Ophthalmol Vis Sci; 2004 May; 45(5):1514-22. PubMed ID: 15111610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction.
    van der Meer P; Lipsic E; Henning RH; Boddeus K; van der Velden J; Voors AA; van Veldhuisen DJ; van Gilst WH; Schoemaker RG
    J Am Coll Cardiol; 2005 Jul; 46(1):125-33. PubMed ID: 15992646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of erythropoietin on posttraumatic place learning in fimbria-fornix transected rats after a 30-day postoperative pause.
    Malá H; Rodriguez Castro M; Dall Jørgensen K; Mogensen J
    J Neurotrauma; 2007 Oct; 24(10):1647-57. PubMed ID: 17970627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain-derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK-1/-2 and Akt pathways.
    Kilic E; Kilic U; Soliz J; Bassetti CL; Gassmann M; Hermann DM
    FASEB J; 2005 Dec; 19(14):2026-8. PubMed ID: 16207820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging and serum biomarkers reflecting the functional efficacy of extended erythropoietin treatment in rats following infantile traumatic brain injury.
    Robinson S; Winer JL; Berkner J; Chan LA; Denson JL; Maxwell JR; Yang Y; Sillerud LO; Tasker RC; Meehan WP; Mannix R; Jantzie LL
    J Neurosurg Pediatr; 2016 Jun; 17(6):739-55. PubMed ID: 26894518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis of cardioprotection by erythropoietin.
    Burger D; Xenocostas A; Feng QP
    Curr Mol Pharmacol; 2009 Jan; 2(1):56-69. PubMed ID: 20021446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The erythropoietin receptor and its expression in tumor cells and other tissues.
    Farrell F; Lee A
    Oncologist; 2004; 9 Suppl 5():18-30. PubMed ID: 15591419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment.
    Wilson J; Yao GL; Raftery J; Bohlius J; Brunskill S; Sandercock J; Bayliss S; Moss P; Stanworth S; Hyde C
    Health Technol Assess; 2007 Apr; 11(13):1-202, iii-iv. PubMed ID: 17408534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The administration of erythropoietin attenuates kidney injury induced by ischemia/reperfusion with increased activation of Wnt/β-catenin signaling.
    Chen X; Wang CC; Song SM; Wei SY; Li JS; Zhao SL; Li B
    J Formos Med Assoc; 2015 May; 114(5):430-7. PubMed ID: 25682558
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.